refinance existing debt as it matures ; · because of our holding company structure , the inability of our subsidiaries to pay dividends to the holding company in sufficient amounts could harm the holding company 's ability to meet its obligations ; · legislative , regulatory or tax changes , both domestic and foreign , that affect the cost of , or demand for , our subsidiaries ' products , the required amount of reserves and or surplus , or otherwise affect our ability to conduct business , including changes to statutory reserve requirements related to secondary guarantees under universal life , such as a change to reserve calculations under actuarial guideline 38 ( also known as the application of the valuation of life insurance policies model regulation , or “ ag38 ” ) , and variable annuity products under actuarial guideline 43 ( also known as commissioners annuity reserve valuation method for variable annuities , or “ ag43 ” ) ; restrictions on revenue sharing and 12b-1 payments ; and the potential for u.s. federal tax reform ; · uncertainty about the effect of rules and regulations to be promulgated under the dodd-frank wall street reform and consumer protection act on us and the economy and the financial services sector in particular ; · the initiation of legal or regulatory proceedings against us , and the outcome of any legal or regulatory proceedings , such as : adverse actions related to present or past business practices common in businesses in which we compete ; adverse decisions in 35 significant actions including , but not limited to , actions brought by federal and state authorities and class action cases ; new decisions that result in changes in law ; and unexpected trial court rulings ; · changes in or sustained low interest rates causing a reduction in investment income , the interest margins of our businesses , estimated gross profits and demand for our products ; · a decline in the equity markets causing a reduction in the sales of our subsidiaries ' products , a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products , an acceleration of the net amortization of deferred acquisition costs ( “ dac ” ) , value of business acquired ( “ voba ” ) , deferred sales inducements ( “ dsi ” ) and deferred front-end loads ( “ dfel ” ) and an increase in liabilities related to guaranteed benefit features of our subsidiaries ' variable annuity products ; · ineffectiveness of our risk management policies and procedures , including various hedging strategies used to offset the effect of changes in the value of liabilities due to changes in the level and volatility of the equity markets and interest rates ; · a deviation in actual experience regarding future persistency , mortality , morbidity , interest rates or equity market returns from the assumptions used in pricing our subsidiaries ' products , in establishing related insurance reserves and in the net amortization of dac , voba , dsi and dfel , which may reduce future earnings ; · changes in gaap , including the potential incorporation of international financial reporting standards ( “ ifrs ” ) into the u.s. financial reporting system , that may result in unanticipated changes to our net income ; · lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition ; · lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings , policy retention , profitability of our insurance subsidiaries and liquidity ; · significant credit , accounting , fraud , corporate governance or other issues that may adversely affect the value of certain investments in our portfolios , as well as counterparties to which we are exposed to credit risk , requiring that we realize losses on investments ; · the effect of acquisitions and divestitures , restructurings , product withdrawals and other unusual items ; · the adequacy and collectibility of reinsurance that we have purchased ; · acts of terrorism , a pandemic , war or other man-made and natural catastrophes that may adversely affect our businesses and the cost and availability of reinsurance ; · competitive conditions , including pricing pressures , new product offerings and the emergence of new competitors , that may affect the level of premiums and fees that our subsidiaries can charge for their products ; · the unknown effect on our subsidiaries ' businesses resulting from changes in the demographics of their client base , as aging baby-boomers move from the asset-accumulation stage to the asset-distribution stage of life ; and · loss of key management , financial planners or wholesalers . the risks included here are not exhaustive . other sections of this report , our quarterly reports on form 10-q , current reports on form 8-k and other documents filed with the securities and exchange commission ( “ sec ” ) include additional factors that could affect our businesses and financial performance , including “ part i – item 1a . risk factors , ” “ part ii – item 7a . quantitative and qualitative disclosures about market risk ” and the risk discussions included in this section under “ critical accounting policies and estimates , ” “ consolidated investments ” and “ reinsurance , ” which are incorporated herein by reference . moreover , we operate in a rapidly changing and competitive environment . new risk factors emerge from time to time , and it is not possible for management to predict all such risk factors . story_separator_special_tag 2010-26 , “ accounting for costs associated with acquiring or renewing insurance contracts ” ( referred to herein as the “ new dac methodology ” ) , which clarifies the types of costs incurred by an insurance entity that can be capitalized in the acquisition of insurance contracts . only those costs incurred that result directly from and are essential to the successful acquisition of new or renewal insurance contracts may be capitalized as deferrable acquisition costs . this determination of deferability must be made on a contract-level basis . this new dac methodology contrasts to the existing guidance we follow that defines deferrable acquisition costs as costs that vary with and are related primarily to new or renewal business , regardless of whether the acquisition efforts were successful or unsuccessful . some examples of acquisition costs that remain subject to deferral as part of the new dac methodology include the following : · employee , agent or broker commissions for successful contract acquisitions ; · wholesaler production bonuses for successful contract acquisitions ; · renewal commissions and bonuses to agents or brokers ; · medical and inspection fees for successful contract acquisitions ; · premium-related taxes and assessments ; and · a portion of the salaries and benefits of certain employees involved in the underwriting , contract issuance and processing , medical and inspection and sales force contract selling functions related to the successful issuance or renewal of an insurance contract . all other acquisition-related costs , including costs incurred by the insurer for soliciting potential customers , market research , training , administration , management of distribution and underwriting functions , unsuccessful acquisition or renewal efforts and product development , are considered non-deferrable acquisition costs and must be expensed in the period incurred . in addition , the following indirect costs are considered non-deferrable acquisition costs as part of the new dac methodology and must be charged to expense in the period incurred : · administrative costs ; · rent ; · depreciation ; · occupancy costs ; · equipment costs ( including data processing equipment dedicated to acquiring insurance contracts ) ; and · other general overhead . we will adopt the new dac methodology effective january 1 , 2012 , and have elected to apply the guidance retrospectively . we expect that our adoption of the new dac methodology will result in an overall reduction in deferrable acquisition costs , partially offset by lower dac amortization , in each of our business segments . we currently estimate that retrospective adoption will result in the restatement of all years presented with a cumulative effect adjustment to the opening balance of retained earnings for the earliest period presented of approximately $ 950 million to $ 1.15 billion . in addition , the adoption of this accounting guidance will result in a lower dac adjustment associated with unrealized gains and losses on afs securities and certain derivatives ; therefore , we will also adjust these dac balances through a cumulative effect adjustment to the opening balance of accumulated other comprehensive income ( loss ) ( “ aoci ” ) . this adjustment is dependent on our unrealized position as of the date of adoption . we believe that the total of our segment results would have declined by approximately 5 % to 7 % for 2011 had we applied the provisions of the new dac methodology during 2011. this decline would not have been uniform across our segments as the effect on the life insurance segment would have been greater due to its products having longer contract lives and its more significant voba balance that is not affected by the new methodology . this estimate does not include changes that management may make to mitigate the effects of this new dac methodology . amortization deferrable acquisition costs for variable annuity and deferred fixed annuity contracts and ul and vul policies are amortized over the lives of the contracts in relation to the incidence of estimated gross profits ( “ egps ” ) derived from the contracts . broker commissions or broker-dealer expenses , which vary with and are related to sales of mutual fund products , respectively , are expensed as incurred . for our traditional products , we amortized deferrable acquisition costs either on a straight-line basis or as a level percent of premium of the related contracts , depending on the block of business . egps vary based on a number of sources including policy persistency , mortality , fee income , investment margins , expense margins and realized gains and losses on investments , including assumptions about the expected level of credit-related losses . each of these sources of profit is , in turn , driven by other factors . for example , assets under management and the spread between earned and 41 credited rates drive investment margins ; net amount at risk ( “ nar ” ) drives the level of cost of insurance ( “ coi ” ) charges and reinsurance premiums . the level of separate account assets under management is driven by changes in the financial markets ( equity and bond markets , hereafter referred to collectively as “ equity markets ” ) and net flows . realized gains and losses on investments include amounts resulting from differences in the actual level of impairments and the levels assumed in calculating egps . we amortize dac , voba , dsi and dfel in proportion to our egps for interest-sensitive products . when actual gross profits are higher in the period than egps , we recognize more amortization than planned . when actual gross profits are lower in the period than egps , we recognize less amortization than planned . in a calendar year where the gross profits for a certain group of policies , or “ cohorts , ” are negative , our actuarial process limits , or floors , the amortization expense offset to zero . for a discussion of the periods

liquidity and capital resources sources of liquidity and cash flow liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety . our principal sources of cash flow from operating activities are insurance premiums and fees and investment income , while sources of cash flows from investing activities result from maturities and sales of invested assets . our operating activities provided cash of $ 1.3 billion , $ 1.7 billion and $ 937 million in 2011 , 2010 and 2009 , respectively . when considering our liquidity and cash flow , it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company , lnc . as a holding company with no operations of its own , lnc derives its cash primarily from its operating subsidiaries . the sources of liquidity of the holding company are principally comprised of dividends and interest payments from subsidiaries , augmented by holding company short-term investments , bank lines of credit and the ongoing availability of long-term public financing under an sec-filed shelf registration statement . these sources of liquidity and cash flow support the general corporate needs of the holding company , including its common and preferred stock dividends , interest and debt service , funding of callable securities , securities repurchases , acquisitions and investment in core businesses . our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes . as the value of a derivative asset declines ( or increases ) , the collateral required to be posted by our counterparties would also decline ( or increase ) .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources sources of liquidity and cash flow liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety . our principal sources of cash flow from operating activities are insurance premiums and fees and investment income , while sources of cash flows from investing activities result from maturities and sales of invested assets . our operating activities provided cash of $ 1.3 billion , $ 1.7 billion and $ 937 million in 2011 , 2010 and 2009 , respectively . when considering our liquidity and cash flow , it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company , lnc . as a holding company with no operations of its own , lnc derives its cash primarily from its operating subsidiaries . the sources of liquidity of the holding company are principally comprised of dividends and interest payments from subsidiaries , augmented by holding company short-term investments , bank lines of credit and the ongoing availability of long-term public financing under an sec-filed shelf registration statement . these sources of liquidity and cash flow support the general corporate needs of the holding company , including its common and preferred stock dividends , interest and debt service , funding of callable securities , securities repurchases , acquisitions and investment in core businesses . our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes . as the value of a derivative asset declines ( or increases ) , the collateral required to be posted by our counterparties would also decline ( or increase ) .
```    
 Suspicious Activity Report : refinance existing debt as it matures ; · because of our holding company structure , the inability of our subsidiaries to pay dividends to the holding company in sufficient amounts could harm the holding company 's ability to meet its obligations ; · legislative , regulatory or tax changes , both domestic and foreign , that affect the cost of , or demand for , our subsidiaries ' products , the required amount of reserves and or surplus , or otherwise affect our ability to conduct business , including changes to statutory reserve requirements related to secondary guarantees under universal life , such as a change to reserve calculations under actuarial guideline 38 ( also known as the application of the valuation of life insurance policies model regulation , or “ ag38 ” ) , and variable annuity products under actuarial guideline 43 ( also known as commissioners annuity reserve valuation method for variable annuities , or “ ag43 ” ) ; restrictions on revenue sharing and 12b-1 payments ; and the potential for u.s. federal tax reform ; · uncertainty about the effect of rules and regulations to be promulgated under the dodd-frank wall street reform and consumer protection act on us and the economy and the financial services sector in particular ; · the initiation of legal or regulatory proceedings against us , and the outcome of any legal or regulatory proceedings , such as : adverse actions related to present or past business practices common in businesses in which we compete ; adverse decisions in 35 significant actions including , but not limited to , actions brought by federal and state authorities and class action cases ; new decisions that result in changes in law ; and unexpected trial court rulings ; · changes in or sustained low interest rates causing a reduction in investment income , the interest margins of our businesses , estimated gross profits and demand for our products ; · a decline in the equity markets causing a reduction in the sales of our subsidiaries ' products , a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products , an acceleration of the net amortization of deferred acquisition costs ( “ dac ” ) , value of business acquired ( “ voba ” ) , deferred sales inducements ( “ dsi ” ) and deferred front-end loads ( “ dfel ” ) and an increase in liabilities related to guaranteed benefit features of our subsidiaries ' variable annuity products ; · ineffectiveness of our risk management policies and procedures , including various hedging strategies used to offset the effect of changes in the value of liabilities due to changes in the level and volatility of the equity markets and interest rates ; · a deviation in actual experience regarding future persistency , mortality , morbidity , interest rates or equity market returns from the assumptions used in pricing our subsidiaries ' products , in establishing related insurance reserves and in the net amortization of dac , voba , dsi and dfel , which may reduce future earnings ; · changes in gaap , including the potential incorporation of international financial reporting standards ( “ ifrs ” ) into the u.s. financial reporting system , that may result in unanticipated changes to our net income ; · lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition ; · lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings , policy retention , profitability of our insurance subsidiaries and liquidity ; · significant credit , accounting , fraud , corporate governance or other issues that may adversely affect the value of certain investments in our portfolios , as well as counterparties to which we are exposed to credit risk , requiring that we realize losses on investments ; · the effect of acquisitions and divestitures , restructurings , product withdrawals and other unusual items ; · the adequacy and collectibility of reinsurance that we have purchased ; · acts of terrorism , a pandemic , war or other man-made and natural catastrophes that may adversely affect our businesses and the cost and availability of reinsurance ; · competitive conditions , including pricing pressures , new product offerings and the emergence of new competitors , that may affect the level of premiums and fees that our subsidiaries can charge for their products ; · the unknown effect on our subsidiaries ' businesses resulting from changes in the demographics of their client base , as aging baby-boomers move from the asset-accumulation stage to the asset-distribution stage of life ; and · loss of key management , financial planners or wholesalers . the risks included here are not exhaustive . other sections of this report , our quarterly reports on form 10-q , current reports on form 8-k and other documents filed with the securities and exchange commission ( “ sec ” ) include additional factors that could affect our businesses and financial performance , including “ part i – item 1a . risk factors , ” “ part ii – item 7a . quantitative and qualitative disclosures about market risk ” and the risk discussions included in this section under “ critical accounting policies and estimates , ” “ consolidated investments ” and “ reinsurance , ” which are incorporated herein by reference . moreover , we operate in a rapidly changing and competitive environment . new risk factors emerge from time to time , and it is not possible for management to predict all such risk factors . story_separator_special_tag 2010-26 , “ accounting for costs associated with acquiring or renewing insurance contracts ” ( referred to herein as the “ new dac methodology ” ) , which clarifies the types of costs incurred by an insurance entity that can be capitalized in the acquisition of insurance contracts . only those costs incurred that result directly from and are essential to the successful acquisition of new or renewal insurance contracts may be capitalized as deferrable acquisition costs . this determination of deferability must be made on a contract-level basis . this new dac methodology contrasts to the existing guidance we follow that defines deferrable acquisition costs as costs that vary with and are related primarily to new or renewal business , regardless of whether the acquisition efforts were successful or unsuccessful . some examples of acquisition costs that remain subject to deferral as part of the new dac methodology include the following : · employee , agent or broker commissions for successful contract acquisitions ; · wholesaler production bonuses for successful contract acquisitions ; · renewal commissions and bonuses to agents or brokers ; · medical and inspection fees for successful contract acquisitions ; · premium-related taxes and assessments ; and · a portion of the salaries and benefits of certain employees involved in the underwriting , contract issuance and processing , medical and inspection and sales force contract selling functions related to the successful issuance or renewal of an insurance contract . all other acquisition-related costs , including costs incurred by the insurer for soliciting potential customers , market research , training , administration , management of distribution and underwriting functions , unsuccessful acquisition or renewal efforts and product development , are considered non-deferrable acquisition costs and must be expensed in the period incurred . in addition , the following indirect costs are considered non-deferrable acquisition costs as part of the new dac methodology and must be charged to expense in the period incurred : · administrative costs ; · rent ; · depreciation ; · occupancy costs ; · equipment costs ( including data processing equipment dedicated to acquiring insurance contracts ) ; and · other general overhead . we will adopt the new dac methodology effective january 1 , 2012 , and have elected to apply the guidance retrospectively . we expect that our adoption of the new dac methodology will result in an overall reduction in deferrable acquisition costs , partially offset by lower dac amortization , in each of our business segments . we currently estimate that retrospective adoption will result in the restatement of all years presented with a cumulative effect adjustment to the opening balance of retained earnings for the earliest period presented of approximately $ 950 million to $ 1.15 billion . in addition , the adoption of this accounting guidance will result in a lower dac adjustment associated with unrealized gains and losses on afs securities and certain derivatives ; therefore , we will also adjust these dac balances through a cumulative effect adjustment to the opening balance of accumulated other comprehensive income ( loss ) ( “ aoci ” ) . this adjustment is dependent on our unrealized position as of the date of adoption . we believe that the total of our segment results would have declined by approximately 5 % to 7 % for 2011 had we applied the provisions of the new dac methodology during 2011. this decline would not have been uniform across our segments as the effect on the life insurance segment would have been greater due to its products having longer contract lives and its more significant voba balance that is not affected by the new methodology . this estimate does not include changes that management may make to mitigate the effects of this new dac methodology . amortization deferrable acquisition costs for variable annuity and deferred fixed annuity contracts and ul and vul policies are amortized over the lives of the contracts in relation to the incidence of estimated gross profits ( “ egps ” ) derived from the contracts . broker commissions or broker-dealer expenses , which vary with and are related to sales of mutual fund products , respectively , are expensed as incurred . for our traditional products , we amortized deferrable acquisition costs either on a straight-line basis or as a level percent of premium of the related contracts , depending on the block of business . egps vary based on a number of sources including policy persistency , mortality , fee income , investment margins , expense margins and realized gains and losses on investments , including assumptions about the expected level of credit-related losses . each of these sources of profit is , in turn , driven by other factors . for example , assets under management and the spread between earned and 41 credited rates drive investment margins ; net amount at risk ( “ nar ” ) drives the level of cost of insurance ( “ coi ” ) charges and reinsurance premiums . the level of separate account assets under management is driven by changes in the financial markets ( equity and bond markets , hereafter referred to collectively as “ equity markets ” ) and net flows . realized gains and losses on investments include amounts resulting from differences in the actual level of impairments and the levels assumed in calculating egps . we amortize dac , voba , dsi and dfel in proportion to our egps for interest-sensitive products . when actual gross profits are higher in the period than egps , we recognize more amortization than planned . when actual gross profits are lower in the period than egps , we recognize less amortization than planned . in a calendar year where the gross profits for a certain group of policies , or “ cohorts , ” are negative , our actuarial process limits , or floors , the amortization expense offset to zero . for a discussion of the periods

